Alnylam Pharma Stock Price (NASDAQ:ALNY)

Add to My Stocks
$122.88 $1.14 (0.94%) ALNY stock closing price Feb 16, 2018 (Closing)
Prev Close* : $121.74
Market Cap:
$12.27B
Day Low: $121.27
52 Week Low: $45.00
Open: $121.89
Volume: -
Day High: $124.03
52 Week High: $147.63
Dividend:
0.00

Latest Stock Market News

Latest Articles

Alnylam Pharma News - From Partners

ALNY Stockcharts

View ALNY PE ratio, PS ratio stocks charts and compare with peers.
ALNY Chart
Note: Compare Alnylam Pharma stock price history with the index and industry peers.

Alnylam Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
131.39
PB ratio (
price to book ratio
)
-999.0000

Alnylam Pharma Returns

ROE
(return on equity)
-50%

Alnylam Pharma Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
0%

ALNY Industry Peers

Company Price Change (%)
Biomarin Pharma (BMRN)84.980.14 (0.16%)
Medivation (MDVN)81.440 (0%)
Sanofi (SNY)39.910.19 (0.48%)
Takeda Pharma (TKPYY)28.280.14 (0.5%)
Merck (MRK)56.290.3 (0.54%)
Arbutus Biopharma (ABUS)5.650.1 (1.74%)
Takeda Pharma (TKPYY)28.280.14 (0.5%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)2.340.18 (8.33%)
Fate Therapeutics (FATE)8.760.65 (8.01%)
Dicerna Pharma (DRNA)10.630.57 (5.67%)
Alkermes (ALKS)67.263.51 (5.51%)
AVID BIOSERVICS (CDMO)2.490.12 (5.06%)
Achillion Pharma (ACHN)3.20.13 (4.23%)
NewLink Genetics (NLNK)7.110.27 (3.95%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Cytokinetics (CYTK)8.0250.63 (7.28%)
MiMedx (MDXG)14.470.96 (6.22%)
Catalyst Biosciences (CBIO)31.082.01 (6.07%)
Advaxis (ADXS)2.510.13 (4.92%)
Insmed (INSM)24.231.14 (4.49%)
Amicus Therapeutics (FOLD)15.170.66 (4.17%)
Alder BioPharma (ALDR)13.550.5 (3.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018

Alnylam Pharmaceuticals, Inc. Stock News - Partner Headlines

Alnylam Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues47.15M41.09M50.56M47.16M66.72M
Net Income-410.1M-290.07M-360.39M-89.22M-106.01M
Total Operating Expense471.74M337.1M455.53M140.1M196.17M
View Alnylam Pharma income statement
balance sheet20162015201420132012
Total Assets1.26B1.39B1.08B420.53M287.52M
Total Liabilities342.58M121.79M143.32M150.18M153.46M
Shareholders Equity920.22M1.26B936.26M270.34M134.05M
View Alnylam Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities17.21M35.11M-29.4M-8.11M-8.96M
Net Cash from (used by) Operating Activities-307.7M-189.14M-165.64M-68.65M-115.6M
Increase (Decrease) in Prop Plant And Equipment-64.55M-12.95M-8.96M-4M-8.34M
View Alnylam Pharma cash flow statement

Alnylam Pharma Stock Message Board

Alnylam Pharma stock price ended the last trading day at $122.88. The total market value as denoted by $12.27B for Alnylam Pharma, is the market value of the company's outstanding shares. Alnylam Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ALNY stock than sell it, then Alnylam Pharma stock price goes up. Conversely, if more investors wanted to sell ALNY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Alnylam Pharma stock quote data shows the number of shares traded. For Ex: 653,512 Alnylam Pharma shares were traded as of last trading day, as seen from Alnylam Pharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Alnylam Pharma dividend per share was 0.00 during the last quarter. Alnylam Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.